Celal Bayar University

About: Celal Bayar University is a education organization based out in Magnesia ad Sipylum, Turkey. It is known for research contribution in the topics: Population & Heat transfer. The organization has 2960 authors who have published 6024 publications receiving 100646 citations.

Use of neural networks for the prediction of the CBR value of some Aegean sands

Abstract: This study deals with the development of an artificial neural network (ANN) and a multiple regression (MR) model that can be employed for estimating the California bearing ratio (CBR) value of some Aegean sands. To achieve this, the results of CBR tests performed on the compacted specimens of nine different Aegean sands with varying soil properties were used in the development of the ANN and MR models. The results of the ANN and MR models were compared with those obtained from the experiments. It is found that the CBR values predicted from the ANN model matched the experimental values much better than the MR model. Moreover, several performance indices, such as coefficient of determination, root-mean-square error, mean absolute error, and variance, were used to evaluate the prediction performance of the ANN and MR models. The ANN model has shown higher prediction performance than the MR model based on the performance indices, which demonstrates the usefulness and efficiency of the ANN model. Thus, the ANN model can be used to predict CBR value of the Aegean sands included in this study as an inexpensive substitute for the laboratory testing, quite easily and efficiently.

ACE I/D gene polymorphism and aerobic endurance development in response to training in a non-elite female cohort

Abstract: Aim. The aim of this study was to investigate the association between ACE gene polymorphism and short- and medium-duration aerobic endurance performance improvements in response to the same training regimen in a non-elite female cohort. Methods. Fifty-five female non-elite Caucasian Turkish athletes trained to enhance running speeds corresponding to 70% and 90% of heart rate reserve (V-HRR70 and V-HRR90 respectively) 30 min running speed performance (V-30min) 3 times per week, for 6 weeks. ACE gene polymorphisms studied by PCR analysis. Results. The distribution of genotypes in the whole cohort was 21.8%, 41.8%, 36.4% for II (n=12), ID (n=23) and DD (n=20), respectively. Subjects with ACE II genotype had significantly higher improvements in V-30min and V-HRR70 than the ACE DD group (P ID>DD (P ID>II (P<0.01) observed in V-HRR90. Conclusion. ACE II genotype may related with better improvements in medium duration aerobic endurance performance whilst ACE DD genotype seems to be more advantageous in performance enhancement in shorter duration and higher intensity endurance activities.

Measurement of CP violation parameters in B0→DK*0 decays

Abstract: An analysis of B0→DK*0 decays is presented, where D represents an admixture of D0 and D¯0 mesons reconstructed in four separate final states: K−π+, π−K+, K+K− and π+π−. The data sample corresponds to 3.0 fb−1 of proton-proton collision, collected by the LHCb experiment. Measurements of several observables are performed, including CP asymmetries. The most precise determination is presented of rB(DK*0), the magnitude of the ratio of the amplitudes of the decay B0→DK+π− with a b→u or a b→c transition, in a Kπ mass region of ±50 MeV/c2 around the K∗(892) mass and for an absolute value of the cosine of the K*0 helicity angle larger than 0.4.

Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic Diseases

Abstract: The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients’ organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.